Bisoxatin

Immunogen Synthetic peptide directed towards the N terminal region of human CBX4 Application Anti-CBX4 antibody produced in rabbit is suitable for western blotting at a concentration of 0.5 &#956g/ml.

Bisbentiamine is a vitamin B1 disulfide derivative that has been shown to have high bioavailability invitro. It is easily digested by cells into vitamin B1.

Application bisBenzimide H 33258 is useful for staining DNA, chromosomes and nuclei. bisBenzimide H 33258 may be used for fluorescence microscopy or flow cytometry.

Application bisBenzimide H 33258 is useful for staining DNA, chromosomes and nuclei. bisBenzimide H 33258 may be used for fluorescence microscopy or flow cytometry.

BT5528 is a bicyclic peptide toxin conjugate, an EphA2 activator. BT5528, made up of a bicyclic peptide and Auristatin E ( HY-15582 ), is derivated from BCY6099. BT5528 shows potent anti-tumor activity without bleeding or coagulation toxicity in

CB-6644 is a selective inhibitor of RUVBL1 / 2 complex with anti-cancer activity. CB-6644 blocks the ATPase activity of RUVBL1/2 with an IC 50 of 15 nM.In VitroCB-6644 (20 µM) interacts with the RUVBL1/2 complex in Ramos cells. CB-6644 (0.001-10 μM:

CB-6644 is a selective inhibitor of RUVBL1 / 2 complex with anti-cancer activity. CB-6644 blocks the ATPase activity of RUVBL1/2 with an IC 50 of 15 nM.In VitroCB-6644 (20 µM) interacts with the RUVBL1/2 complex in Ramos cells. CB-6644 (0.001-10 μM:

Dasatinib is a 2-aminothiazole-derived inhibitor of Src family kinases. Dasatinib inhibits c-Abl and Bcr-Abl tyrosine kinase activity and shows efficacy against imatinib-resistant Bcr-Abl mutations.

Biochem/physiol Actions MZ1 is a BRD4 degrader composed of pan-BET selective bromodomain inhibitor and the E3 ubiquitin ligase VHL ligand that induces preferential degradation of BRD4 over BRD2 and BRD3. MZ1exhibits antiproliferative effects in

Biochem/physiol Actions MZ1 is a BRD4 degrader composed of pan-BET selective bromodomain inhibitor and the E3 ubiquitin ligase VHL ligand that induces preferential degradation of BRD4 over BRD2 and BRD3. MZ1exhibits antiproliferative effects in

YB-0158 (Wnt pathway inhibitor 2) is a reverse-turn peptidomimetic and a potent colorectal cancer stem cell (CSC) targeting agent. YB-0158 disrupts Sam68-Src interactions and induces apoptosis in CRC cells. Anti-cancer activitiesIn VitroYB-0158 (0.2

YB-0158 (Wnt pathway inhibitor 2) is a reverse-turn peptidomimetic and a potent colorectal cancer stem cell (CSC) targeting agent. YB-0158 disrupts Sam68-Src interactions and induces apoptosis in CRC cells. Anti-cancer activitiesIn VitroYB-0158 (0.2